Fortitude Family Office »

Vor Biopharma shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $552 31 17.84

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mid-cap Etf Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Avantis International Small Cap Value Etf Etf (AVDV)

View all positions for Fortitude Family Office

Top funds holding Vor Biopharma

TCG Crossover Management
RA Capital Management
Fcpm Iii Services B.v.
VR Adviser
Frazier Life Sciences Management
FMR
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Vanguard Capital Management
Susquehanna International
Caligan Partners
BlackRock
Vanguard Group
Logos Global Management
Boothbay Fund Management

View all funds holding Vor Biopharma